2020 Mid Year Update: Mass Tort and Class Action Litigation Outlook

While many courtrooms across the country were closed in response to the COVID-19 pandemic, there are several mass torts that continued making significant progress despite the legal hiatus. Two of these were cited in our 2020 forecast: JUUL The JUUL MDL (Northern District of California) has continued to move forward since the end of 2019. … Continue reading “2020 Mid Year Update: Mass Tort and Class Action Litigation Outlook”

Fresh talk of a settlement between Bayer and Roundup cancer patients

There was renewed talk of a potential settlement this week between Bayer AG and tens of thousands of cancer patients as a key court hearing looms next week. According to a report in Bloomberg, lawyers for Bayer have reached verbal agreements with U.S. lawyers representing at least 50,000 plaintiffs who are suing Monsanto over claims … Continue reading “Fresh talk of a settlement between Bayer and Roundup cancer patients”

How Will J&J’s Move to Discontinue Baby Powder Sales Impact Its Ongoing Talc Litigation Now?

On May 19, 2020, Johnson & Johnson announced it is discontinuing North American sales of its talc-based baby powder, a product it has defended for decades in the face of lawsuits filed by consumers who say it caused cancer. This move likely would not have happened without the public attention drawn to individuals who have … Continue reading “How Will J&J’s Move to Discontinue Baby Powder Sales Impact Its Ongoing Talc Litigation Now?”

Litigation Update: J&J to Discontinue Sales of Baby Powder in North America

Even as the company continues to defend the safety of its flagship product, pharmaceutical giant Johnson & Johnson announced on Tuesday that it would discontinue selling its talc-based baby powder product in the U.S.   Facing tens of thousands of lawsuits from women alleging their ovarian cancer was caused by asbestos contamination of J&J baby powder, … Continue reading “Litigation Update: J&J to Discontinue Sales of Baby Powder in North America”

Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson

On May 8, the California 2nd District Court of Appeals reinstated thousands of cases pending against drug manufacturer Johnson & Johnson involving the antipsychotic drug Risperdal.  The March, 2017 lower court ruling in the Risperdal and Invega Products Liability Cases had granted motions for summary judgment in favor of J&J on preemption grounds in five … Continue reading “Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson”

Litigation Update: Zantac Leadership Is Selected

On Friday, May 8th, District Judge Robin Rosenberg, of the U.S. District Court for the Southern District of Florida, appointed 26 lawyers to a range of leadership positions to the Zantac MDL which was transferred to Florida last February. Initially, the Judge had created an interim team to handle some special tasks given the Covid-19 … Continue reading “Litigation Update: Zantac Leadership Is Selected”

Bayer shareholder meeting draws protests, pleas from cancer patients

The Bayer AG annual shareholders’ meeting got underway Tuesday in Germany, drawing the attention of not only investors and analysts but also activists, lawyers and cancer patients who want to see Bayer make amends for alleged misdeeds by Monsanto, which Bayer bought two years ago. The meeting was to be an in-person event in Bonn, … Continue reading “Bayer shareholder meeting draws protests, pleas from cancer patients”

Questions for the Bayer Shareholder Meeting: by Carey Gillam

Earlier this year, our colleague Carey Gillam was offered a speaking slot by a Bayer shareholders’ group at the company’s annual meeting in Bonn, Germany. Due to Covid-19, the in-person meeting has been canceled and the Bayer shareholders convened in a virtual meeting on April 28 at 10:00 Central European Summer Time (CEST). In lieu of … Continue reading “Questions for the Bayer Shareholder Meeting: by Carey Gillam”

Litigation Update: Pharmacies’ Petition to Overturn Untimely Dispensing Allegations Granted in the Opioid MDL

On April 15, the U.S. Court of Appeals for the Sixth Circuit unanimously granted the writ of mandamus filed by several major pharmacy chains finding that U.S. District Judge Dan Polster of the Northern District of Ohio, who is presiding over the 2,600 case MDL, improperly allowed dispensing allegations to be added to the complaints … Continue reading “Litigation Update: Pharmacies’ Petition to Overturn Untimely Dispensing Allegations Granted in the Opioid MDL”

Litigation Update: Johnson & Johnson Files Motion for a New Punitives Trial

In February, after a massive punitive damages verdict, Johnson and Johnson filed a motion seeking a new trial on the issue of the award as well as motions asking for judgment notwithstanding the verdict and remittitur.  In its filings, J&J claimed that the plaintiffs’ subpoenaing of the company chief executive, Alex Gorsky, was inappropriate, causing … Continue reading “Litigation Update: Johnson & Johnson Files Motion for a New Punitives Trial”

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved